Hi everyone
I’m Eleanor and I work in the policy team at Breast Cancer Now.
We’re looking to hear from anyone with experience of the treatment elacestrant (also known as orserdu) which is used for treating ER-positive, HER2-negative advanced breast cancer with an ESR1 mutation. You may have received the treatment through a clinical trial.
The treatment is being assessed to see if it should be made available through the NHS and we would love to hear your views.
If you can help, please get in touch via policy@breastcancernow.org
Thanks so much